2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Giant Cell Tumor of Bone: new trials by email Literature Review of Giant Cell Tumor of Bone trials Research Report on Giant Cell Tumor of Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Dose-density of Denosumab for Unresectable GCTB Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA] - Bone Giant Cell Tumor | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 2 | 2019-09-26 | 2021-01-06 |
| Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) Zoledronic acid - Giant Cell Tumor of Bone, Osteoclastoma | Phase 2 | Terminated | Leiden University Medical Center | 15 | 2008-12-01 | 2016-01-26 |
Giant Cell Tumors (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2)
Denosumab (1) · Zoledronic Acid (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Leiden University Medical Center (1)
Netherlands (2) · Belgium (1) · Italy (1) · Spain (1) · United Kingdom (1)
A H Taminiau, MD PhD (1) · Emanuela Palmerini (1) · H Gelderblom, MD PhD (1) · Hans Gelderblom (1) · J R Kroep, MD PhD (1) · N A Hamdy, MD PhD (1) · P C Hogendoorn, MD PhD (1) · P D Dijkstra, MD PhD (1) · S E Papapoulos, MD PhD (1)
2018 (1)